As a result of scientific research, Swiss scientists finally achieved positive results in the development of a drug that can treat one of the types of bone marrow cancer.
The drug LBH589, in combination with two hormonal drugs, bortezomib and dexamethasone, was able to increase cell survival without disease progression in patients with multiple myeloma, a tumor that appears in the bone marrow plasma cells and disrupts the production of healthy blood cells. Every year, this disease affects 1-5 people out of a million around the world. As a rule, the risk of myeloma increases after 50 years.
According to a representative of the research group, the effect of the drug is to block the main enzyme of cancer cells, causing stress and death.
Comments